Importantly, loss of membranous EpCAM coincided with increasing cytoplasmic staining at the tumour front (detected by polyclonal antibody), suggesting altered cellular localisation due to abnormal post-translational processing of EpCAM rather than reduced expression of this antigen. Here, EPCAM is linked to neoplasm.